Comparison between compliance of fluticasone propionate diskhaler and of fluticasone propionate diskus in adult bronchial asthma patients

Respiration

Volumn 73, Issue 5, 2006, Pages 680-684

  Hasegawa, Takashi ^a   Suzuki, Eiichi ^a   Fujimori, Katsuya ^b   Sakagami, Takuro ^c   Toyabe, Shinichi ^a   Akazawa, Kouhei ^a   Kawano, Kenji ^d   Haraguchi, Michihiko ^e   Toyama, Joji ^f   Arakawa, Masaaki ^c   Satoh, Hiroshi ^a   Gejyo, Fumitake ^c  

^a NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^b Niigata Prefectural Kamo Hospital   (Japan)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^d NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^e NIIGATA CITY GENERAL HOSPITAL   (Japan)

^f Joetsu General Hospital   (Japan)

Author keywords

Bronchial asthma; Drug compliance; Fluticasone

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; SALMETEROL; THEOPHYLLINE;

ADULT; AGED; ASTHMA; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PHARMACIST; PHARMACY; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; TREATMENT DURATION;

ADMINISTRATION, INHALATION; ADULT; ANDROSTADIENES; ASTHMA; BRONCHODILATOR AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; QUESTIONNAIRES;

EID: 33749243721     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095313     Document Type: Review

References (27)

1. Makino S, Furusho K, Miyamoto T, Ohta K: Asthma Prevention and Management Guidelines. 1998, Japan (JGL): English version. Int Arch Allergy Immunol 2000;121:1-78.
2. National Asthma Education and Prevention Program: Guidelines for the Diagnosis and Management of Asthma. Update on Selected Topics 2002. Bethesda, National Institute of Health, 2002.
3. Kunkel G, Schaper C, Noga O, Schlafke S, Lemmnitz G, Kohler S: Efficacy, safety, and acceptance of beclomethasone dipropionate administered via a new dry powder inhaler or a standard CFC metered-dose inhaler in asthma patients. Respiration 2003;70:399-406.
4. Hasegawa T, Suzuki E, Muramatsu Y, Koya T, Mashima I, Kondoh A, Takagi H, Fujimori K, Arakawa M, Yoshizawa H, Gejyo F: Questionnaire-based analysis of the current level of asthma control and management in Niigata Prefecture, Japan: changes from 1998 to 2000. Allergol Int 2004;53:135-144.
5. Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH: Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest 2000;117:542-550.
6. Cramwers JA, Spilker B: Patients Compliance in Medical Practice and Clinical Trials. New York, Raven Press, 1991.
7. Janmeja AK, Das SK, Bhargava R, Chavan BS: Psychotherapy improves compliance with tuberculosis treatment. Respiration 2005;72:375-380.
8. Pieters WR, Stallaert RA, Prins J, Greefhorst AP, Bosman HG, van Uffelen R, Schreurs AJ, van Helmond JL, Janssen PG: A study on the clinical equivalence and patient preference of fluticasone propionate 250 microgram twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients. J Asthma 1998;35:337-345.
9. Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM: Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma. Ann Allergy Asthma Immunol 1999;82:273-280.
10. Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG, Mahajan P, House KW: Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. J Allergy Clin Immunol 1998;102:32-38.
11. Mahajan P, Okamoto L: Patient satisfaction with the Diskhaler and the Diskus inhaler, a new multidose power delivery system for the treatment of asthma. Clin Ther 1997;19:1126-1134.
12. Griffith S: A review of the factors associated with patient compliance and the taking of prescribed medicines. Br J Gen Pract 1990;40:114-116.
13. Leenen FH, Wilson TW, Bolli P, Larochelle P, Myers M, Handa SP, Boileau G, Tanner J: Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring. Can J Cardiol 1997;13:914-920.
14. Iskedjian M, Einarson TR, MacKeigan LD, Shear N, Addis A, Mittmann N, Ilersich AL: Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther 2002;24:302-316.
15. van Schayck CP, Bijl-Hofland ID, Folgering H, Cloosterman SGM, Akkermans R, van den Elshout F: Influence of two different inhalation devices on therapy compliance in asthmatic patients. Scand J Prim Health Care 2002;20:126-128.
16. Price DD, McGrath PA, Raffi A, Bruckingham B: The validation of the visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983:17;45-56.
17. Jonasson G, Carlsen KH, Sodal A, Jonasson C, Mowinckel P: Patient compliance in a clinical trial with inhaled budesonide in children with mild asthma. Eur Respir J 1999;14:150-154.
18. Apter AJ, Reisine ST, Affleck G, Barrows E, ZuWallack RL: Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences. Am J Respir Crit Care Med 1998;157:1810-1817.
19. Yeung M, O'Connor SA, Parry DT, Cochrane GM: Compliance with prescribed drug therapy in asthma. Respir Med 1994;88:31-35.
20. Mann MC, Eliasson O, Patel K, ZuWallack RL: An evaluation of severity-modulated compliance with q.i.d. dosing of inhaled beclomethasone. Chest 1992;102:1342-1346.
21. van der Palen J, Klein JJ, Rovers MM: Compliance with inhaled medication and self-treatment guidelines following a self-management programme in adult asthmatics. Eur Respir J 1997;10:652-657.
22. Van Grunsven PM, van Schayck CP, van Herwaarden CL, Akkermans RP, van Weel C: Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA). J Asthma 2000;37:225-234.
23. Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connor BJ, Barnes PJ: A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 1997:337;1412-1418.
24. Condemi JJ, Goldstein S, Kalberg C, Yancey S, Emmett A, Rickard K, the Salmeterol Study Group: The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Ann Allergy Asthma Immunol 1999;82:383-389.
25. Yurdakul AS, Calisir HC, Tunctan B, Ogretensoy M: Comparison of second controller medications in addition to inhaled corticosteroid in patients with moderate asthma. Respir Med 2002;96:322-329.
26. Kelloway JS, Wyatt RA, Adlis SA: Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994;154:1349-1352.
27. Hasegawa T, Suzuki E, Tayabe S, Akazawa K, Kawano K, Haraguchi M, Toyama J, Watanabe Y, Watanabe N, Arakawa M, Satoh H, Gejyo F: Drug compliance in patients with bronchial asthma: relation among compliance with different types of antiasthmatic drug and association with daily administration frequency. Allergy Int 2005;54:547-553.